According to Wiendl H. et al. in their studies of microglia, macrophages and endothelial cells located in MS lesions showed a significant expression of HLA-G and its inhibitory receptors for ILT-2 and ILT-4. This evidence concerns the gene HLA-G and myeloid sarcoma.